Department of Chemical Engineering, College of Engineering, National Taiwan University, 1 Sec. 4, Roosevelt Rd., Taipei 106, Taiwan.
Department of Biomedical Sciences and Engineering, National Central University, 300 Zhongda Rd., Taoyuan 320, Taiwan.
Stem Cell Res Ther. 2022 Jun 28;13(1):276. doi: 10.1186/s13287-022-02948-3.
Adipose-derived stem cell (ASC) has been considered as a desirable source for cell therapy. In contrast to combining scaffold materials with cells, ASCs can be fabricated into scaffold-free three-dimensional (3D) constructs to promote regeneration at tissue level. However, previous reports have found decreased expression of vascular endothelial growth factor (VEGF) in ASC sheets. In this study, we aimed to integrate ASC spheroids into ASC sheets to enhance the angiogenic capability of cell sheets.
ASCs were seeded in agarose microwells to generate uniform cell spheroids with adjustable size, while extracellular matrix deposition could be stimulated by ascorbic acid 2-phosphate to form ASC sheets. RNA sequencing was performed to identify the transcriptomic profiles of ASC spheroids and sheets relative to monolayer ASCs. By transferring ASC spheroids onto ASC sheets, the spheroid sheet composites could be successfully fabricated after a short-term co-culture, and their angiogenic potential was evaluated in vitro and in ovo.
RNA sequencing analysis revealed that upregulation of angiogenesis-related genes was found only in ASC spheroids. The stimulating effect of spheroid formation on ASCs toward endothelial lineage was demonstrated by enhanced CD31 expression, which maintained after ASC spheroids were seeded on cell sheets. Relative to ASC sheets, enhanced expression of VEGF and hepatocyte growth factor was also noted in ASC spheroid sheets, and conditioned medium of ASC spheroid sheets significantly enhanced tube formation of endothelial cells in vitro. Moreover, chick embryo chorioallantoic membrane assay showed a significantly higher capillary density with more branch points after applying ASC spheroid sheets, and immunohistochemistry also revealed a significantly higher ratio of CD31-positive area.
In the spheroid sheet construct, ASC spheroids can augment the pro-angiogenesis capability of ASC sheets without the use of exogenous biomaterial or genetic manipulation. The strategy of this composite system holds promise as an advance in 3D culture technique of ASCs for future application in angiogenesis and regeneration therapies.
脂肪来源干细胞(ASC)被认为是细胞治疗的理想来源。与将支架材料与细胞结合相比,ASC 可被制成无支架的三维(3D)构建体,以促进组织水平的再生。然而,先前的报告发现 ASC 薄片中血管内皮生长因子(VEGF)的表达降低。在这项研究中,我们旨在将 ASC 球体整合到 ASC 薄片中,以增强细胞片的血管生成能力。
将 ASC 接种到琼脂糖微井中,以生成具有可调节尺寸的均匀细胞球体,同时可以通过抗坏血酸 2-磷酸刺激细胞外基质沉积以形成 ASC 薄片。进行 RNA 测序以鉴定 ASC 球体和薄片相对于单层 ASC 的转录组图谱。通过将 ASC 球体转移到 ASC 薄片上,可以在短期共培养后成功制造出球体薄片复合材料,并在体外和体内评估其血管生成潜力。
RNA 测序分析显示,仅在 ASC 球体中发现了血管生成相关基因的上调。通过增强 CD31 表达证明了球体形成对 ASC 向内皮谱系的刺激作用,并且在将 ASC 球体接种到细胞薄片上后仍能维持。与 ASC 薄片相比,在 ASC 球体薄片中还观察到 VEGF 和肝细胞生长因子的表达增强,并且 ASC 球体薄片的条件培养基在体外显著增强了内皮细胞的管形成。此外,鸡胚绒毛尿囊膜试验显示,应用 ASC 球体薄片后,毛细血管密度更高,分支点更多,免疫组织化学也显示 CD31 阳性面积的比例显著更高。
在球体薄片构建体中,ASC 球体可以增强 ASC 薄片的促血管生成能力,而无需使用外源性生物材料或基因操作。该复合系统的策略有望成为 ASC 3D 培养技术的进步,为未来的血管生成和再生治疗应用提供帮助。